Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise M O'Connell

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The American Journal of Tropical Medicine and Hygiene|August 3, 2016
Molecular Diagnostics for Soil-Transmitted HelminthsElise M O'Connell, Thomas B Nutman
Current Opinion in Infectious Diseases|September 2, 2020
Subarachnoid neurocysticercosis: emerging concepts and treatmentTheodore E Nash, Elise M O'Connell
Immunology and Allergy Clinics of North America|July 27, 2015
Eosinophilia in Infectious DiseasesElise M O'Connell, Thomas B Nutman
Trends in Parasitology|October 17, 2017
Mining Filarial Genomes for Diagnostic and Therapeutic TargetsSasisekhar Bennuru, Elise M O'Connell, Papa M Drame, et al.
Plos Neglected Tropical Diseases|July 21, 2017
Defining the target and the effect of imatinib on the filarial c-Abl homologueElise M O'Connell, Olena Kamenyeva, Sara Lustigman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2019
A Novel, Highly Sensitive Quantitative Polymerase Chain Reaction Assay for the Diagnosis of Subarachnoid and Ventricular Neurocysticercosis and for Assessing Responses to TreatmentElise M O'Connell, Sarah Harrison, Eric Dahlstrom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2020
The Local Inflammatory Profile and Predictors of Treatment Success in Subarachnoid NeurocysticercosisSarah Harrison, Lauren Thumm, Theodore E Nash, et al.
The Journal of Infectious Diseases|February 7, 2015
Targeting Filarial Abl-like Kinases: Orally Available, Food and Drug Administration-Approved Tyrosine Kinase Inhibitors Are Microfilaricidal and MacrofilaricidalElise M O'Connell, Sasisekhar Bennuru, Cathy Steel, et al.
Emerging Infectious Diseases|June 22, 2023
Triplex ELISA for Assessing Durability of Taenia solium Seropositivity after Neurocysticercosis CureNina L Tang, Theodore E Nash, Madelynn Corda, et al.
American Heart Journal|December 13, 2006
Evaluation of dyslipidemia in the emergency department: impact of cholesterol testing on subsequent therapyAndra L Blomkalns, Elise M O'Connell, Caroline E Eady, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The American Journal of Tropical Medicine and Hygiene|August 3, 2016
Molecular Diagnostics for Soil-Transmitted HelminthsElise M O'Connell, Thomas B Nutman
Current Opinion in Infectious Diseases|September 2, 2020
Subarachnoid neurocysticercosis: emerging concepts and treatmentTheodore E Nash, Elise M O'Connell
Immunology and Allergy Clinics of North America|July 27, 2015
Eosinophilia in Infectious DiseasesElise M O'Connell, Thomas B Nutman
Trends in Parasitology|October 17, 2017
Mining Filarial Genomes for Diagnostic and Therapeutic TargetsSasisekhar Bennuru, Elise M O'Connell, Papa M Drame, et al.
Plos Neglected Tropical Diseases|July 21, 2017
Defining the target and the effect of imatinib on the filarial c-Abl homologueElise M O'Connell, Olena Kamenyeva, Sara Lustigman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2019
A Novel, Highly Sensitive Quantitative Polymerase Chain Reaction Assay for the Diagnosis of Subarachnoid and Ventricular Neurocysticercosis and for Assessing Responses to TreatmentElise M O'Connell, Sarah Harrison, Eric Dahlstrom, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2020
The Local Inflammatory Profile and Predictors of Treatment Success in Subarachnoid NeurocysticercosisSarah Harrison, Lauren Thumm, Theodore E Nash, et al.
The Journal of Infectious Diseases|February 7, 2015
Targeting Filarial Abl-like Kinases: Orally Available, Food and Drug Administration-Approved Tyrosine Kinase Inhibitors Are Microfilaricidal and MacrofilaricidalElise M O'Connell, Sasisekhar Bennuru, Cathy Steel, et al.
Emerging Infectious Diseases|June 22, 2023
Triplex ELISA for Assessing Durability of Taenia solium Seropositivity after Neurocysticercosis CureNina L Tang, Theodore E Nash, Madelynn Corda, et al.
American Heart Journal|December 13, 2006
Evaluation of dyslipidemia in the emergency department: impact of cholesterol testing on subsequent therapyAndra L Blomkalns, Elise M O'Connell, Caroline E Eady, et al.
Pageof 4